MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma
Skeletal Radiology · 2026-10 · 55 (10) · 2613-2625
DOI: 10.1007/s00256-026-05284-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skeletal Radiology, online erschienen am 30.06.2026. Verfasst von Majid Chalian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, UW Radiology-Roosevelt Clinic, 4245 Roosevel…. Hauptthemen laut MEDLINE: Radiomics, Neoadjuvant Therapy, Radioimmunotherapy, Magnetic Resonance Imaging. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Prediction of treatment outcomes is essential for improving clinical management, particularly in patients with soft tissue sarcoma, where treatment options remain suboptimal. Given the limitations of current therapies, there is increasing interest in combining neoadjuvant radiotherapy with immunotherapy, referred to as neoadjuvant radioimmunotherapy (NRIT). We aim to develop a predictive model for assessing pathologic treatment response in patients undergoing NRIT or chemoradiotherapy, integrating radiomic features with radiologist assessments, clinical data, and pathology findings. MATERIALS AND METHODS: Radiomic and semantic features were extracted from pre- and post-treatment MRI scans. The XGBoost algorithm was used for feature selection and model development. Models included a model based on clinical variables and semantic features, a model based on radiomic features and clinical features and a model using all available features. RESULTS: Study cohort included 213 patients (mean age of 54 years, male/female of 1.6). There were 17 patients in the prospective arm. The best model used all radiomic, clinical, and semantics features. It achieved an area under the receiver operating characteristic curve (AUC) of 0.72 (95% CI = 0.51-0.89) on the hold-out testing set. CONCLUSION: Multi-modal radiomic-based models are effective in identifying patients at higher risk of non-response to neoadjuvant therapy. Furthermore, the performance of multi-modal radiomics-based models exceeded those based solely on radiologist evaluations. Our findings underscore the potential of radiomics in enhancing precision medicine by enabling identification of treatment response in STS patients undergoing NRIT before surgical excision of the tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, UW Radiology-Roosevelt Clinic, 4245 Roosevelt Way NE, Box 354755, Seattle, WA, USA. m.chalian@gmail.com.
- OncoRad Research Core, Department of Radiology, University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA. m.chalian@gmail.com.
- Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, UW Radiology-Roosevelt Clinic, 4245 Roosevelt Way NE, Box 354755, Seattle, WA, USA.
- Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA.
- Department of Radiology, Mercy Catholic Medical Center - Trinity Health Mid-Atlantic, PA, Darby, USA.
- OncoRad Research Core, Department of Radiology, University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA.
Zitieren
APA
Chalian, M., Alipour, E., Pooyan, A., Haseli, S., Shomal Zadeh, F., Park, C., Mantilla, J. G., Jones, A. D., Schaub, S. K., Cranmer, L. D., Kinahan, P. E., & Nyflot, M. J. (2026). MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma. Skeletal Radiology, 55(10), 2613-2625. https://doi.org/10.1007/s00256-026-05284-2
Vancouver
Chalian M, Alipour E, Pooyan A, Haseli S, Shomal Zadeh F, Park C, et al. MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma. Skeletal Radiology. 2026;55(10):2613-2625. doi:10.1007/s00256-026-05284-2
BibTeX
@article{Chalian2026,
author = {Chalian, Majid and Alipour, Ehsan and Pooyan, Atefe and Haseli, Sara and Shomal Zadeh, Firoozeh and Park, Chankue and Mantilla, Jose G and Jones, Austin D and Schaub, Stephanie K and Cranmer, Lee D and Kinahan, Paul E and Nyflot, Matthew J},
title = {MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma},
journal = {Skeletal Radiology},
year = {2026},
volume = {55},
number = {10},
pages = {2613--2625},
doi = {10.1007/s00256-026-05284-2}
}
EUVIMED